With Supplements, ADT in Prostate Cancer of Little Threat to Bone Density Study suggests calcium/vitamin D alone sufficient for long-duration therapy Jun 03, 2021
Vaccination, Screening Succeeds in Cervical and Prostate Cancers Cervical cancer rates on the decline; PSA testing benefits younger Black men May 19, 2021
SBRT Safe for Cancer Patients With Multiple Metastases Late adverse events in phase I trial indicate need for extended follow-up May 03, 2021
Treatment Type a Non-Factor in Prostate Cancer Patients' Anxiety Researchers emphasized importance of psychological interventions as problems arise Apr 29, 2021
Late ADT a Problem in Prostate Cancer Late dosing of LHRH agonists happens too frequently, researchers report Apr 22, 2021
No More Men Need to Die From Transrectal Prostate Biopsies A movement toward transperineal biopsies Apr 21, 2021
More Benefit With Taxane for Aggressive Metastatic Prostate Cancer Higher clinical benefit rate with front-line cabazitaxel versus androgen receptor inhibitor Apr 12, 2021
Mixed Results for Immunotherapy in Metastatic Prostate Cancer Combination trial missed response endpoint but exceeded historical results Apr 11, 2021
CCR Score Could Offer ADT-Free Path in Higher-Risk Prostate Cancer Large proportion of intermediate- to high-risk patients could avoid aggressive therapy Feb 12, 2021
Radionuclide Tx Wins in Third-Line Metastatic CRPC Early trial shows improved PFS, response rates versus cabazitaxel Feb 11, 2021
Hit and Miss in Castration-Resistant Prostate Cancer No OS benefit with apalutamide-abiraterone, despite improved PFS Feb 11, 2021
Brain Tumor Risk Upped With Synthetic Progestogen Absolute risk still low, however, and product not currently approved in U.S. Feb 03, 2021
Whole-Pelvis Tops Prostate-Only RT in High-Risk Disease Practice impact may hinge on knowledge versus clinical bias Jan 28, 2021
Is This Really Cancer? Movement builds to classify Gleason 6 prostate lesions as nonmalignant Jan 09, 2021
PARP Inhibitors Linked With Blood Cancer Risk Incidence of MDS/AML under 1%, but further investigation warranted as indications broaden Dec 28, 2020
High-Risk Prostate Cancer Patients Can Wait 6 Months for Surgery: Study Can be considered low priority procedure during COVID-19 pandemic, researchers say Dec 08, 2020
FDA OKs 'Game Changer' Radiotracer for Prostate Cancer PET imaging drug detected metastasis at initial diagnosis, outperformed standard for PSA recurrence Dec 01, 2020
Al Roker's Prostate Cancer Morning show stalwart's diagnosis highlights discrepancies for Black men Nov 10, 2020
Focal RT Boost in High-Risk Prostate Cancer Cuts PSA Relapse Rates of biochemical relapse cut in half with boost to 95 Gy Oct 29, 2020
COVID-19 in Health Workers; Stimulating New White Blood Cells: It's TTHealthWatch! This week's topics also include gene expression and COVID infection, and outbreaks in childcare settings Sep 19, 2020 podcast
Surgery Rates Doubled for High-Risk Prostate Cancer Use of prostatectomy nearly equaled radiotherapy in 2016 Aug 31, 2020
Lower COVID-19 Risk With ADT for Prostate Cancer Higher risk of infection, more severe disease in men who did not receive hormones Aug 14, 2020
The Serious Conversation: Delivering Bad News by Telemedicine As office visits move online, clinicians discuss breaking life-changing diagnoses virtually Jul 13, 2020
Oral ADT Slashes Heart Risk in Advanced Prostate Cancer Novel GnRH antagonist has potential to be new standard, says researcher May 30, 2020
Studies Make Case for Hormonal Therapy in nmCRPC Prolonged survival with three different androgen signaling inhibitors May 30, 2020
HCQ Linked to Harm in Cancer Patients Combination with azithromycin associated with three-fold risk of mortality, registry study shows May 28, 2020
BMI, Weight Change Linked to Prostate Ca Outcomes Gain or loss of body weight both show risk May 07, 2020
DOAC Works in Cancer-Related VTE, No Tradeoff in Bleeds Apixaban monotherapy matches dalteparin in non-inferiority trial Mar 29, 2020
Bell Ringing Not So Joyous for Cancer Patients? Greater treatment-related distress for those who rang bell at end of treatment Feb 10, 2020
'Shock Jock' Don Imus: Not Your Usual Role Model Often despicable on-air, sure, but his approach to prostate cancer worth emulating Jan 03, 2020
Prostate Cancer and the Waiting Game Active surveillance isn't just about avoiding surgery -- it's also buying time Dec 27, 2019
Beta Blockers No Help in Advanced Prostate Cancer Findings question earlier retrospective data that pointed to possible survival benefit Dec 05, 2019
Docetaxel First May Boost Survival in mCRPC Superior outcomes observed versus approach where chemo follows newer agents Dec 05, 2019
MRI-Guided Ultrasound Zaps Low-Risk Prostate Cancer TULSA devices achieves prostate volume reduction Dec 04, 2019
Why the Lower Risk of Prostate Cancer in Men With Diabetes? Findings from large cohort study do not support one leading hypothesis, researchers say Nov 06, 2019
In Memory of Gerald Chodak, MD Pioneer of active surveillance for men with low-risk prostate cancer died last week Oct 03, 2019
New Standard in Third-Line Metastatic CRPC Cabazitaxel tops more anti-androgen in patients with "short-ish" response to abiraterone or enzalutamide Oct 01, 2019
How Often Does MRI Miss the Mark in Prostate Ca? Retrospective study finds 21% of patients with prostate cancer pathology did not have ROI on MRI Sep 25, 2019
